Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda
Multidrug-resistant tuberculosis (MDR-TB) has become a major threat to the control of tuberculosis globally. Uganda is among the countries with a relatively high prevalence of tuberculosis despite significant control efforts. In this study, the drug resistance of Mycobacterium tuberculosis to rifamp...
Saved in:
Main Authors: | Lisa Nkatha Micheni, Kennedy Kassaza, Hellen Kinyi, Ibrahim Ntulume, Joel Bazira |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7d1ee0d6b6224e53891af967dabc3c84 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda.
by: Lisa Nkatha Micheni, et al.
Published: (2021) -
High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
by: Naima Fasih, et al.
Published: (2012) -
The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide
by: Lin HS, et al.
Published: (2016) -
Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates—Chennai, India, 2013–2016
by: Sembulingam Tamilzhalagan, et al.
Published: (2021) -
Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.
by: Yukari C Manabe, et al.
Published: (2012)